Intraperitoneal pyrophosphate treatment reduces renal calcifications in Npt2a null mice

Daniel Caballero1, Yuwen Li2,3, Jonathan Fetene1

  • 1Department of Medicine, Section Endocrinology, Yale University School of Medicine, New Haven, CT, United States of America.

Plos One
|July 14, 2017
PubMed

Insights

Pyrophosphate (PPi) protects against kidney calcification in Npt2a-/- mice. Increasing urinary PPi levels may offer a novel strategy for preventing nephrocalcinosis and kidney stones in phosphaturic disorders.

Area of Science:

  • Nephrology
  • Mineral Metabolism
  • Molecular Biology

Background:

  • Mutations in phosphate transporters NPT2a and NPT2c are linked to kidney stones and nephrocalcinosis.
  • The roles of genetics, diet, and pyrophosphate (PPi) in renal mineral deposit formation are not fully understood.

Purpose of the Study:

  • To investigate the protective role of pyrophosphate (PPi) in a mouse model of renal calcification.
  • To explore PPi as a potential therapeutic target for phosphaturic disorders.

Main Methods:

  • Utilized Npt2a-/- mice to model renal calcifications.
  • Assessed urinary PPi excretion in Npt2a-/- and wild-type (WT) mice.
  • Examined the effect of hypomorphic Extracellular nucleotide pyrophosphatase phosphodiesterase 1 (Enpp1asj/asj) alleles on renal calcification.
  • Administered sodium pyrophosphate intraperitoneally to evaluate its impact on calcification.

Main Results:

  • Npt2a-/- mice exhibited elevated urinary PPi excretion compared to WT mice.
  • Reduced urinary PPi in Npt2a-/- mice with Enpp1asj/asj alleles exacerbated renal calcifications.
  • Intraperitoneal sodium pyrophosphate administration decreased renal calcifications in Npt2a-/- mice.

Conclusions:

  • Urinary pyrophosphate (PPi) acts as a protective factor against renal mineral deposits in Npt2a-/- mice.
  • Modulating urinary PPi levels may represent a novel therapeutic approach for nephrocalcinosis and nephrolithiasis.
  • Further research in humans is warranted to confirm the therapeutic potential of urinary PPi.

Related Concept Videos

Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
485
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
303
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
672
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
532
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
478
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
372